IDEAYA Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,384	2,581	2,146	2,075	818	800
Market Cap Growth	14.47%	20.30%	3.40%	153.65%	2.24%	140.60%
Enterprise Value	1,516	1,636	1,004	1,614	453	466
Last Close Price	28.00	29.40	24.60	31.80	16.80	20.60
PS Ratio	12.80	13.86	317.33	98.07	17.17	32.57
PB Ratio	2.74	2.96	2.10	3.69	2.50	3.02
P/TBV Ratio	2.74	2.96	2.10	3.69	2.50	3.02
EV/Sales Ratio	8.17	8.78	148.56	76.31	9.51	18.96
EV/FCF Ratio	-24.23	-	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.02	0.01	0.01	0.02
Net Debt / Equity Ratio	-1.00	-1.00	-1.00	-1.01	-1.06	-1.20
Net Debt / EBITDA Ratio	6.52	6.52	3.28	4.77	6.12	7.48
Net Debt / FCF Ratio	13.91	13.91	4.23	5.36	4.08	6.21
Asset Turnover	0.20	0.20	0.01	0.05	0.13	0.08
Quick Ratio	10.97	10.97	14.68	19.38	11.51	5.49
Current Ratio	11.34	11.34	14.97	19.65	11.68	5.56
Return on Equity (ROE)	-10.92%	-10.92%	-32.67%	-23.28%	-18.02%	-19.91%
Return on Assets (ROA)	-8.92%	-8.92%	-23.05%	-16.20%	-10.15%	-9.25%
Return on Capital Employed (ROCE)	-15.20%	-15.20%	-30.30%	-21.60%	-17.50%	-15.00%
Earnings Yield	-4.06%	-3.75%	-12.36%	-4.92%	-6.71%	-5.47%
FCF Yield	-2.62%	-2.42%	-11.32%	-5.13%	-10.37%	-6.42%
Buyback Yield / Dilution	-8.33%	-8.33%	-42.00%	-38.79%	-17.57%	-42.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.